High-Throughput Drug Screening Identifies a Potent Wnt Inhibitor that Promotes Airway Basal Stem Cell Homeostasis
Open Access
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 30 (7) , 2055-2064.e5
Abstract
No abstract availableKeywords
Funding Information
- Jonsson Comprehensive Cancer Center, University of California, Los Angeles
- Tobacco-Related Disease Research Program
- National Institutes of Health
This publication has 34 references indexed in Scilit:
- ΔN-Tp63 Mediates Wnt/β-Catenin-Induced Inhibition of Differentiation in Basal Stem Cells of Mucociliary EpitheliaCell Reports, 2019
- High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cellsJournal of Clinical Investigation, 2016
- A Small-Molecule Antagonist of the β-Catenin/TCF4 Interaction Blocks the Self-Renewal of Cancer Stem Cells and Suppresses TumorigenesisCancer Research, 2016
- The Collaborative Drug Discovery (CDD) Database2013
- Wnt/β-catenin signaling directly regulates Foxj1 expression and ciliogenesis in zebrafish Kupffer’s vesicleDevelopment, 2012
- β‐Catenin determines upper airway progenitor cell fate and preinvasive squamous lung cancer progression by modulating epithelial–mesenchymal transitionThe Journal of Pathology, 2011
- Tracheal Basal CellsThe American Journal of Pathology, 2010
- Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinomaOncogene, 2009
- Phosphorylation of β-Catenin by AKT Promotes β-Catenin Transcriptional ActivityJournal of Biological Chemistry, 2007
- p63 Expression in Lung CarcinomaApplied Immunohistochemistry & Molecular Morphology, 2004